Edition:
India

Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

76.90EUR
9:48pm IST
Change (% chg)

€-0.80 (-1.03%)
Prev Close
€77.70
Open
€77.90
Day's High
€77.90
Day's Low
€76.70
Volume
75,529
Avg. Vol
144,375
52-wk High
€79.80
52-wk Low
€45.00

Select another date:

Fri, Dec 15 2017

BRIEF-Biomerieux Appoints Alexandre Merieux As CEO And Chairman

* ALEXANDRE MÉRIEUX APPOINTED CHAIRMAN AND CEO OF BIOMÉRIEUX Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Veneto Banca seals deal with Attestor over BIM stake sale

* signed an agreement with Trinity Investments Designated Activity Company, an investment company managed by Attestor Capital, over sale of its stake in BIM

BRIEF-Biomerieux Q3 sales up at ‍​1.67 billion euros

* Q3 SALES EUR ‍​1.67 BILLION VERSUS EUR 1.51 BILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Biomerieux H1 operating income rises to 163 million euros

* IS NOW TARGETING ORGANIC SALES GROWTH FOR FULL YEAR OF BETWEEN 9 PCT AND 10 PCT

BRIEF-Bim Q2 net profit rises 50% to 216.4 mln lira, revises 2017 revenue growth outlook to 20-23%

* REPORTED ON MONDAY Q2 REVENUE OF 6.21 BILLION LIRA VERSUS 4.91 BILLION LIRA YEAR AGO

BRIEF-Biomérieux receives FDA clearance for expanded pathogen identification capability on VITEK® MS

* BIOMÉRIEUX RECEIVES FDA CLEARANCE FOR EXPANDED PATHOGEN IDENTIFICATION CAPABILITY ON VITEK® MS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Sysmex and Biomérieux agreed to dissolve JV Sysmex Biomérieux co., ltd.

* SYSMEX AND BIOMÉRIEUX AGREED TO DISSOLVE THE JOINT VENTURE SYSMEX BIOMÉRIEUX CO., LTD.

Select another date: